BCL2 and metabolic dysfunction-associated steatotic liver disease: In addition, a recent study has investigated the role of VitD in non-alcoholic fatty liver disease in rats and reported a similar result found in our study: VitD injection enhances the expression of Bcl2 compared to the group fed only with an HFD [41].